Preventive Medicine Reports,
Journal Year:
2024,
Volume and Issue:
46, P. 102857 - 102857
Published: Aug. 13, 2024
Human
papillomavirus
(HPV)
commonly
causes
transmissible
diseases
worldwide;
however,
HPV
vaccines
are
not
available
among
some
at-risk
populations.
Since
2017,
vaccination
has
been
recommended
for
females
aged
11-12
years
in
Thailand.
However,
studies
on
the
coverage
and
prevalence
limited.
This
study
aimed
to
explore
factors
associated
with
Thai
university
students.
Immunity Inflammation and Disease,
Journal Year:
2024,
Volume and Issue:
12(4)
Published: April 1, 2024
Abstract
Background
Respiratory
syncytial
virus
(RSV)
is
the
world's
leading
cause
of
viral
acute
lower
respiratory
infections
(ALRI)
in
infants.
WHO
has
identified
maternal
RSV
vaccination
a
priority
and
candidate
vaccines
are
development;
however,
vaccine
hesitancy
remains
an
impediment
to
successful
implementation
immunization.
This
study,
largest
antenatal
survey
conducted
to‐date,
aimed
examine
awareness,
likely
acceptance
pregnancy,
attitudes
vaccination.
Methods
Pregnant
women
all
gestations
attending
clinic
university
maternity
hospital
Ireland
were
invited
participate.
An
information
leaflet
provided,
consent
obtained,
administered
examining
willingness
avail
vaccination,
factors
influencing
acceptability
preferred
sources
assistance.
Research
Ethics
Committee
(REC)
approval
general
data
protection
regulation
(GDPR)
guidelines
followed.
Results
528
completed
survey.
A
large
proportion
(75.6%)
had
never
heard
RSV,
yet
48.5%
would
still
vaccine,
45.8%
undecided
only
5.3%
not.
The
main
factor
making
acceptable
(76.4%)
was
that
it
protects
their
infant
from
illness
(
p
<
.001,
CV
0.336
for
association
with
acceptance)
practitioner
(GP)
guidance
source
decision‐making
(57.7%).
Conclusions
Despite
low
levels
awareness
pregnant
open
availing
Maternal
immunization
strategies
need
focus
on
infant's
RSV‐associated
ALRI
along
safety,
build
interdisciplinary
collaboration
maternal,
neonatal,
primary
care
public
health
services.
Vaccine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 126790 - 126790
Published: Jan. 1, 2025
Respiratory
syncytial
virus
(RSV)
is
the
leading
cause
of
bronchiolitis
and
pneumonia
in
infants
can
lead
to
severe
respiratory
distress,
especially
very
young
infants.
No
specific
treatments
exist
for
RSV.
However,
new
preventative
strategies
have
become
available
including
RSV
vaccine
pregnant
women
monoclonal
antibody
This
study
aimed
identify
understand
barriers
facilitators
uptake
a
determine
their
underlying
choices
maternal
immunisation
program.
Additionally,
investigated
choice
vaccination
or
administration
long-lasting
Eligible
participants
were
residing
Australia
aged
18
years
older.
Focus
group
discussions
individual
online
interviews
conducted
data
analysed
using
thematic
analysis
approach.
A
total
34
participated
focus
interviews,
with
an
average
age
years.
The
identified
themes
categorised
into
four
overarching
domains:
1)
motivators
vaccinating
during
pregnancy
safeguard
babies
prevent
diseases,
2)
safety
concerns,
uncertainties
regarding
effectiveness,
hesitancy
arising
from
COVID-19
experiences,
3)
preferred
promotion
strategies,
constant
reminders/prompts,
personalised
messages,
campaign
focusing
on
serious
outcomes
diverse/lay
languages,
recommendations
local
obstetricians
health
authorities,
4)
clear
recommendation
policies
preference
over
infant
immunisation.
was
generally
welcomed
by
our
comparing
other
strategies.
Preferences
program
included
diversity
"nudge"
reminders,
healthcare
providers.
Vaccines,
Journal Year:
2025,
Volume and Issue:
13(2), P. 159 - 159
Published: Feb. 6, 2025
Background:
New
strategies
for
respiratory
syncytial
virus
(RSV)
prevention
are
available
and
in
development,
but
their
acceptance
is
crucial
to
effectiveness.
Objectives:
This
systematic
review
aims
summarize
current
quantitative
qualitative
evidence
regarding
knowledge
attitudes
relating
RSV
prevention.
Methods:
Six
databases
(PubMed,
Scopus,
APA
PsycArticles;
PsycInfo;
CINAHL
Complete;
Psychology
Behavioral
Sciences
Collection)
two
preprint
repositories
(medRxiv
Preprints)
were
searched
up
until
23
December
2024
(PROSPERO:
CRD42024602351).
Results:
Sixty-one
articles
included,
focusing
on
vaccination
the
elderly
adults
at
risk
(n
=
10)
or
pregnant
people
24,
of
which
8
also
examined
preferences
maternal
vs.
infant
immunization)
immunization
27,
16
focused
palivizumab,
with
6
adherence
its
monthly
administration).
Eighteen
assessed
healthcare
professionals.
Overall,
findings
showed
limited
awareness
generally
positive
towards
moderate
high
intentions
uptake
rates.
Protection
against
disease
perceived
severity
promoted
acceptance,
whereas
concerns
about
side
effects
hindered
it.
Maternal
was
more
acceptable
than
immunization.
Conclusions:
Attitudes
options
favorable.
Should
become
available,
may
depend
characteristics,
how
they
framed
presented.
These
insights
highlight
importance
education
grounded
decision-making
literature,
while
recognizing
likely
favorable
reception
preventive
measures
across
target
age-populations.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(4), P. 418 - 418
Published: April 15, 2024
Background:
This
study
was
conducted
to
assess
parents’
willingness
vaccinate
their
children
with
the
RSV
vaccine
and
key
predictors
of
this
intention
among
parents
in
Italy.
Methods:
Data
were
collected
using
an
anonymous
self-administered
questionnaire
from
April
November
2023,
targeting
public
kindergartens
nursery
schools
southern
The
survey
assessed
socio-demographic
characteristics,
health-related
details,
child’s
health
status,
attitudes
toward
infection
its
vaccine,
source(s)
information.
Results:
A
total
404
agreed
participate
study.
Only
18.2%
participants
very
concerned
that
could
get
infected
by
RSV,
concern
more
likely
whose
child
had
been
diagnosed
bronchiolitis,
those
who
received
information
HCWs,
heard
needed
additional
Almost
half
(51.3%)
willing
child,
inclination
fathers,
employed
parents,
daughters,
Conclusions:
An
educational
campaign
regarding
a
future
especially
about
safety
efficacy,
is
order
improve
willingness.
Vaccine,
Journal Year:
2025,
Volume and Issue:
55, P. 127062 - 127062
Published: March 31, 2025
Respiratory
syncytial
virus
(RSV)
is
a
major
cause
of
respiratory
infections
and
hospitalizations
in
Canadian
infants.
Recently,
Health
Canada
approved
two
novel
immunizing
products:
vaccine
given
during
pregnancy
monoclonal
antibody
for
This
study
assessed
knowledge,
attitudes,
intentions
regarding
RSV
its
prevention
among
pregnant
individuals.
A
mixed-methods
was
conducted
Quebec
from
October
to
December
2023.
Pregnant
individuals
were
recruited
through
targeted
Facebook
advertisements.
Data
collected
phases:
Phase
1
involved
an
online
survey
assess
knowledge
RSV,
attitudes
toward
immunization,
both
immunization
products,
followed
by
qualitative
interviews
2
explore
factors
impacting
decision-making
preferences
prevention.
Survey
data
analyzed
using
descriptive
statistics;
interview
thematic
analysis.
Among
participants
(n
=
803),
68.4
%
reported
some
RSV.
Intention
products
high,
with
88.1
willing
receive
the
92
%,
administer
antibodies
their
majority
(69
%)
preferred
vaccination
over
antibodies.
The
desire
protect
infant
severe
complications
key
motivating
factor
acceptance
new
products.
Other
determinants
included
safety,
efficacy,
recommendations
healthcare
providers.
Qualitative
25)
highlighted
safety
concerns
expectant
parents
about
these
importance
clear
evidence-based
providers
also
emphasized.
demonstrated
high
level
interest
infants,
whether
or
Recommendations
availability
information
on
efficacy
will
be
move
intention
action.
Human Vaccines & Immunotherapeutics,
Journal Year:
2025,
Volume and Issue:
21(1)
Published: April 17, 2025
The
objectives
of
the
cross-sectional
survey
were
to
examine
knowledge,
attitudes,
and
hesitancy
among
pregnant
post-partum
women
toward
recommended
vaccinations
identify
determinants.
was
conducted
from
July
September
2024
in
Naples,
Italy.
Out
a
total
585
participants,
64.1%
had
been
infected
with
at
least
one
MMRV
diseases
47.3%
received
vaccinations.
Only
21.4%
knew
that
post-partum,
this
more
frequent
healthcare
workers
(HCWs)
or
those
who
partner
working
sector
no
history
infections.
overall
mean
Vaccine
Hesitancy
Scale
(VHS)
score
24.1
43.6%
high-hesitant
(score
≥
25).
Participants
higher
level
education,
non-Italian
nationality,
infections
pregnancy-related
health
problems,
aware
complications
during
pregnancy,
perception
knowledge
about
acquired
information
HCWs,
needed
further
odds
low
regarding
as
measured
by
VHS
instrument.
More
than
one-third
expressed
willingness
receive
post-partum.
Respondents
information,
not
high
vaccine
hesitant
willing
findings
revealed
an
inadequate
significant
prevalence
public
efforts,
informative
campaigns
utility
are
needed.
Behavioral Medicine,
Journal Year:
2024,
Volume and Issue:
51(1), P. 1 - 6
Published: Nov. 15, 2024
Respiratory
Syncytial
Virus
(RSV)
is
a
common
respiratory
pathogen
with
high
morbidity
and
mortality,
especially
in
children
under
two
years
of
age.
Severe
RSV
infection
poses
significant
threat
to
healthcare
systems,
making
vaccination
an
utmost
need.
In
August
2023,
the
U.S.
FDA
approved
maternal
vaccine
prevent
lower
tract
disease
(LRTD)
infants
throughout
their
first
six
months
life.
This
cross-sectional
survey
was
designed
evaluate
pregnant
women's
willingness
receive
during
pregnancy.
An
anonymous
administered
from
April
2023
December
women
aged
above
16
old
attending
gynecology
wards
randomly
selected
public
private
hospitals
Crete.
The
primary
outcome
intention
vaccine.
Univariable
multivariable
analyses
were
carried
out
identify
factors
associated
get
vaccinated.
Questionnaires
distributed
sample
335
females
who
agreed
participate
this
study.
vaccinated
against
positively
educational
level,
presence
school-age
children,
awareness,
routine
pregnancy
vaccines
according
National
Immunization
Program
(NIP),
previous
COVID-19.
majority
not
familiar
term
upcoming
campaign
regarding
its
required
improve
perceptions
support
workers
promoting
it
upon
availability
Greece.
Vaccine,
Journal Year:
2024,
Volume and Issue:
42(20), P. 126094 - 126094
Published: June 29, 2024
Maternal
immunisation
is
a
powerful
tool
to
protect
both
pregnant
women
and
their
children.
A
new
maternal
RSV
vaccine
holds
promise
newborns
from
RSV-associated
illness
in
the
first
few
months
of
life,
but
no
official
recommendation
has
been
made
Germany.
Since
causes
significant
burden
paediatric
hospital
admissions,
we
consider
it
pertinent
opportunity
review
barriers
vaccination
Germany,
which
might
also
apply
other
settings.
Access
for
Germany
shaped
by
an
interplay
legal,
regulatory,
institutional,
sociocultural
factors,
with
less
permissive
clinical
research
environment,
delays
roll-out,
lower
acceptance
healthcare
professionals
population.
Actionable
recommendations
improve
availability
uptake
include
coordination
national
regulatory
bodies
reduce
delays,
awareness
literacy
campaigns
health
general
public,
capacity
building
research.